Health

  • Home
  • Business
    • Internet
    • Market
    • Stock
  • Parent Category
    • Child Category 1
      • Sub Child Category 1
      • Sub Child Category 2
      • Sub Child Category 3
    • Child Category 2
    • Child Category 3
    • Child Category 4
  • Featured
  • Health
    • Childcare
    • Doctors
  • Home
  • Business
    • Internet
    • Market
    • Stock
  • Downloads
    • Dvd
    • Games
    • Software
      • Office
  • Parent Category
    • Child Category 1
      • Sub Child Category 1
      • Sub Child Category 2
      • Sub Child Category 3
    • Child Category 2
    • Child Category 3
    • Child Category 4
  • Featured
  • Health
    • Childcare
    • Doctors
  • Uncategorized

Friday, August 11, 2023

‘Major step forward’ for adult patients as new blood cancer drug receives FDA approval

 August 11, 2023     Health, Health News Today on Fox News     No comments   

The U.S. Food and Drug Administration (FDA) has granted accelerated approval for Talvey, a new antibody-based therapy for adult patients with tough-to-treat blood cancers such as multiple myeloma. The drug is made by Johnson & Johnson. 

This is a "major step forward" for the myeloma field, according to Dr. Ola Landgren, M.D., PhD, chief of the Myeloma Program at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine.

"This is the first myeloma drug designed to target the protein called GPRC5D, which is expressed on the surface of myeloma cells," Landgren told Fox News Digital. 

"It is a new mechanism of action."

NOVEL CANCER TREATMENT OFFERS NEW HOPE WHEN CHEMO AND RADIATION FAIL: ‘BIG CHANGE IN PEOPLE'S LIVES'

The FDA grants "accelerated approval" to enable earlier availability of medications that treat serious conditions, according to its website.

Given the "huge unmet clinical need," Landgren said there is an ongoing need to continue developing safe, effective drugs to target the disease. 

"This drug is an example of that important momentum," he said.

Talvey (talquetamab) is intended for multiple myeloma patients who have received at least four prior types of treatment and have a "poor prognosis," per a press release from Johnson & Johnson.

NEW AI TECH AIMS TO DETECT THE ORIGIN OF CANCERS FOR OPTIMAL TREATMENTS: ‘AN IMPORTANT STEP’

The drug has been approved as a weekly or biweekly injection administered by physicians.

In clinical studies, Talvey showed "impressive response rates" in myeloma patients who had received prior treatments, said Landgren, who is a renowned hematologist/oncologist specializing in multiple myeloma, smoldering myeloma and related plasma cell disorders.

"The overall response rate is 70% in patients who failed four prior lines of myeloma therapy," he said.

"A major clinical issue is that the myeloma tumor cells eventually develop resistance to our therapies," he went on. "For patients who fail several lines of therapy, eventually, there may not be many treatment options left."

Because it is an immunotherapy drug, Talvey has the potential to cause immunosuppression, which may lead to an increased risk of infections, Landgren warned.

The most common adverse effects included an altered or impaired sense of taste, dry mouth and difficulty swallowing. 

Some patients also experienced weight loss, skin reactions, serious infections, low white blood cell count and low blood platelets, per the press release.

"Trained health care providers know what to look for clinically and how to do lab work to monitor the individual patient’s immune status," Landgren told Fox News Digital. "If everything is done correctly, these drugs are overall very safe and effective."

For patients just starting on the drug, the first few doses are given in the hospital because there is an early risk of low-grade fever and immunological reactions, although Landgren said these symptoms are manageable and usually resolve quickly. 

JUST 4 MINUTES OF INTENSE DAILY ACTIVITY COULD SLASH CANCER RISK AMONG ‘NON-EXERCISERS,’ STUDY FINDS

"Ongoing studies are seeking to define optimal ways to pre-medicate patients for the first few doses to limit side effects such as fever and immunological reactions, so these drugs can be given outpatient from day one," he said. 

"We are not yet there, but I think we are moving in this direction."

With the large number of new, effective and safe drugs, Landgren said "the future is bright" for patients with multiple myeloma. 

"We are moving from chemotherapy to immunotherapies," he said. "We are able to achieve high rates of no detectable disease (called minimal residual disease-MRD-negativity) in myeloma patients."

In another mark of progress, overall survival for patients with myeloma is improving every year, the doctor noted. 

"When I was in fellowship, overall survival for myeloma was one to two years — these days, we are talking 10 to 20 years or longer," Landgren said. 

"We still need to develop curative therapies," he said. "We (at Sylvester) and other groups are working on that."

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Given that myeloma is considered a rare cancer — affecting 35,000 patients every year in the U.S. — the doctor noted that a key aspect is for patients to have access to specialized care.

A myeloma specialist can review the patient’s individual case, develop an optimal treatment plan and optimize the person's prognosis and quality of life, he said.



from Health News Today on Fox News https://ift.tt/zt9Aedo
  • Share This:  
  •  Facebook
  •  Twitter
  •  Google+
  •  Stumble
  •  Digg
Email ThisBlogThis!Share to XShare to Facebook

Related Posts:

  • FOX NEWS: WHO says it will provide $5 COVID-19 tests to lower-income countries WHO says it will provide $5 COVID-19 tests to lower-income countries The tests will provide results in under 30 minutes compared to hours or days … Read More
  • Coronavirus face masks made with silk are better than cotton, study findsWhen choosing a fabric to make a homemade face mask to protect against the novel coronavirus, silk is better than cotton, namely when used in conjunct… Read More
  • FOX NEWS: Coronavirus face masks made with silk are better than cotton, study finds Coronavirus face masks made with silk are better than cotton, study finds When choosing a fabric to make a homemade face mask to protect against t… Read More
  • WHO says it will provide $5 COVID-19 tests to lower-income countriesThe tests will provide results in under 30 minutes compared to hours or days and will enable the expansion of testing, particularly in countries that&… Read More
  • FOX NEWS: Recent coronavirus cases doubled among young adults, CDC says Recent coronavirus cases doubled among young adults, CDC says From early August into the following month, weekly coronavirus cases among adults ag… Read More
Newer Post Older Post Home

0 comments:

Post a Comment

Popular Posts

  • Ozempic ‘microdosing’ is the new weight-loss trend: Should you try it?
    A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. With approximately 70% of...
  • Helping Stroke Patients Regain Movement in their Hands
    By BY PAM BELLUCK from NYT Health https://ift.tt/6uNPHMD
  • As eating disorders increase among college students, here's how parents can help: ‘Early intervention is key’
    While most of us have heard about the "Freshman 15" — the stereotypical first-year weight gain among college students — a growing ...

Recent Posts

Categories

  • Health News Today on Fox News
  • FOX NEWS
  • Fox News : Health
  • Health
  • Health News Today on Fox News
  • Healthy tips
  • NYT

Unordered List

Pages

  • Home

Text Widget

Blog Archive

  • June 2025 (15)
  • May 2025 (88)
  • April 2025 (84)
  • March 2025 (88)
  • February 2025 (70)
  • January 2025 (72)
  • December 2024 (81)
  • November 2024 (70)
  • October 2024 (82)
  • September 2024 (75)
  • August 2024 (82)
  • July 2024 (79)
  • June 2024 (74)
  • May 2024 (73)
  • April 2024 (78)
  • March 2024 (75)
  • February 2024 (78)
  • January 2024 (78)
  • December 2023 (60)
  • November 2023 (80)
  • October 2023 (74)
  • September 2023 (75)
  • August 2023 (85)
  • July 2023 (67)
  • June 2023 (58)
  • May 2023 (100)
  • April 2023 (105)
  • March 2023 (118)
  • February 2023 (84)
  • January 2023 (87)
  • December 2022 (69)
  • November 2022 (64)
  • October 2022 (78)
  • September 2022 (74)
  • August 2022 (110)
  • July 2022 (109)
  • June 2022 (127)
  • May 2022 (95)
  • April 2022 (109)
  • March 2022 (140)
  • February 2022 (138)
  • January 2022 (170)
  • December 2021 (182)
  • November 2021 (213)
  • October 2021 (506)
  • September 2021 (539)
  • August 2021 (564)
  • July 2021 (590)
  • June 2021 (556)
  • May 2021 (544)
  • April 2021 (310)
  • March 2021 (331)
  • February 2021 (301)
  • January 2021 (326)
  • December 2020 (521)
  • November 2020 (403)
  • October 2020 (537)
  • September 2020 (554)
  • August 2020 (431)
  • July 2020 (647)
  • June 2020 (610)
  • May 2020 (659)
  • April 2020 (681)
  • March 2020 (729)
  • February 2020 (564)
  • January 2020 (483)
  • December 2019 (396)
  • November 2019 (416)
  • October 2019 (526)
  • September 2019 (486)
  • August 2019 (441)
  • July 2019 (394)
  • June 2019 (381)
  • May 2019 (510)
  • April 2019 (471)
  • March 2019 (560)
  • February 2019 (403)
  • January 2019 (530)
  • December 2018 (382)
  • November 2018 (378)
  • October 2018 (510)
  • September 2018 (297)
Powered by Blogger.

Report Abuse

Formulir Kontak



Search This Blog

Find Us On Facebook

Labels

  • Health News Today on Fox News
  • FOX NEWS
  • Fox News : Health
  • Health
  • Health News Today on Fox News
  • Healthy tips
  • NYT

Flickr Images

Most Popular

  • Ozempic ‘microdosing’ is the new weight-loss trend: Should you try it?
    A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. With approximately 70% of...
  • Helping Stroke Patients Regain Movement in their Hands
    By BY PAM BELLUCK from NYT Health https://ift.tt/6uNPHMD
  • As eating disorders increase among college students, here's how parents can help: ‘Early intervention is key’
    While most of us have heard about the "Freshman 15" — the stereotypical first-year weight gain among college students — a growing ...
  • Pioneer of America's global HIV/AIDS program recalls hope after years of despair
    Through his office window at what was then one of Africa's few modern clinics dealing with HIV and AIDS , the man who now oversees the U...
  • Free COVID tests will again be available from US government starting next week
    The U.S. government is reactivating the program that mails free COVID-19 tests to Americans' homes upon request. Effective Sept. 25, h...
  • New COVID vaccine push is ‘anti-human,’ says Florida surgeon general: ‘Major safety concern’
    The new COVID-19 vaccine is now available at participating pharmacies and health care providers, and the Centers for Disease Control (CDC) ...
  • AI tech aims to help patients catch disease early even reverse their biological age
    In humanity's quest to live longer, healthier lives, technology — particularly artificial intelligence — is playing an ever-bigger role...
  • US scores D+ for preterm birth rates, says new report: ‘Falling further behind’
    The rate of preterm births remains alarmingly high in the U.S., according to the latest March of Dimes Report Card. The figure was around ...
  • FOX NEWS: Vermont fertility doctor accused of using his own sperm to inseminate woman 41 years ago: lawsuit
    Vermont fertility doctor accused of using his own sperm to inseminate woman 41 years ago: lawsuit A child conceived in 1977 through art...
  • Carbon monoxide deaths are climbing, putting families in peril: ‘My son is lucky to be alive’
    Often dubbed "the silent killer," carbon monoxide is colorless and odorless — it’s been shown to cause severe injury or death in h...

Sample Text

Copyright © 2025 Health | Powered by Blogger
Design by Hardeep Asrani | Blogger Theme by NewBloggerThemes.com | Distributed By Gooyaabi Templates